3D Versus Low-Temperature Thermoplastic Relative Motion Orthosis: MP Joint Stabilization
NCT07926178, Not applicable, Completed, Enver Guven
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | 3D Versus Low-Temperature Thermoplastic Relative Motion Orthosis: MP Joint Stabilization | ClinicalTrials.gov |
| NCT number | NCT07926178 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 30 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Enver Guven | ClinicalTrials.gov |
| Conditions | Relative Motion Flexion Orthosis Evaluation | ClinicalTrials.gov |
| Interventions | 3D-Printed TPU Relative Motion Flexion Orthosis, 3D-Printed PLA Relative Motion Flexion Orthosis, Low-Temperature Thermoplastic Relative Motion Flexion Orthosis | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | MCP Joint Stabilization | At the end of each 2-day orthosis wearing period (3 assessments per participant). | The metacarpophalangeal (MCP) joint angle of the third digit of the dominant hand was measured in degrees using a goniometer after each orthosis wearing period. All orthoses were designed to maintain the MCP joint at 30 degrees of flexion. The measured joint angles were compared among three relative motion flexion (RMF) orthoses fabricated from 3D-printed thermoplastic polyurethane (TPU), 3D-printed polylactic acid (PLA), and conventional low-temperature thermoplastic (LTT). Values closer to 30 degrees indicated more accurate maintenance of the target joint position. | ClinicalTrials.gov |
| Secondary | QUEST 2.0 Total Satisfaction Score | At the end of each 2-day orthosis wearing period (3 assessments per participant). | Overall user satisfaction was assessed using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0). The questionnaire includes 12 items covering device-related satisfaction (8 items) and service-related satisfaction (4 items). Each item is rated on a 5-point Likert scale, with higher scores indicating greater satisfaction. Total satisfaction scores were compared across TPU, PLA, and LTT orthoses. | ClinicalTrials.gov |
| Secondary | QUEST 2.0 Device Satisfaction Score | At the end of each 2-day orthosis wearing period (3 assessments per participant). | Device-related satisfaction was assessed using the eight device items of the QUEST 2.0 questionnaire: dimensions, weight, adjustability, safety, durability, ease of use, comfort, and effectiveness. Each item is rated on a 5-point Likert scale, with higher scores indicating greater satisfaction. Device satisfaction scores were compared among TPU, PLA, and LTT orthoses. | ClinicalTrials.gov |
| Secondary | QUEST 2.0 Service Satisfaction Score | At the end of each 2-day orthosis wearing period (3 assessments per participant). | Service-related satisfaction was assessed using the four service items of the QUEST 2.0 questionnaire, covering maintenance, repair, professional services, and follow-up. Each item is rated on a 5-point Likert scale, with higher scores indicating greater satisfaction. Service satisfaction scores were compared among TPU, PLA, and LTT orthoses. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)